Author

H. U. Scherer

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 3 Approach:experimental assay· 3 Organism:human· 3 Assay:proteomics· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:differential expression· 1 Assay:flow cytometry· 1 Approach:statistical model· 1

Frequent Co-Authors

D. van der Woude· 2 shared M. Wuhrer· 2 shared R. E. M. Toes· 2 shared A. H. M. van der Helm-van Mil· 1 shared A. Kawakami· 1 shared C. Bloechl· 1 shared D. van Schaardenburg· 1 shared E. Dominguez-Vega· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

D. van der Woude

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Fc proteoforms of ACPA IgG discriminate autoimmune responses in plasma and synovial fluid of rheumatoid arthritis patients and associate with disease activity

C. Bloechl, E. M. Stork, H. U. Scherer, R. E. M. Toes, M. Wuhrer, E. Dominguez-Vega

The paper identifies Fc proteoforms of ACPA IgG that distinguish autoimmune responses in RA patients and correlate with disease activity.

bioRxiv · Apr 4, 2024Immunology

Autoreactive B cells in rheumatoid arthritis consist of activated CXCR3+ memory B cells and plasmablasts

S. Reijm, J. C. Kwekkeboom, N. J. Blomberg, J. Suurmond, D. van der Woude, R. E. Toes, H. U. Scherer

The paper identifies CXCR3+ memory B cells and plasmablasts as autoreactive B cells in rheumatoid arthritis, showing cross-reactivity against PTM antigens and high CXCR3 expression.

bioRxiv · May 19, 2023 · PreprintImmunology

ACPA-IgG variable domain glycosylation increases before the onset of rheumatoid arthritis and stabilizes thereafter; a cross-sectional study encompassing over 1500 samples

T. Kissel, L. Hafkenscheid, T. J. van Wesemael, M. Tamai, S.-y. Kawashiri, A. Kawakami, H. El-Gabalawy, D. van Schaardenburg, S. Rantapaa Dahlqvist, M. Wuhrer, A. H. M. van der Helm-van Mil, R. Allaart, D. van der Woude, H. U. Scherer, R. E. M. Toes, T. W. J. Huizinga

This study shows ACPA-IgG variable domain glycosylation increases before rheumatoid arthritis onset and stabilizes later, with lower levels at onset correlating with drug-free remission.

bioRxiv · Nov 5, 2021Immunology